Correlation Between Telix Pharmaceuticals and Grace Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Grace Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Grace Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telix Pharmaceuticals Limited and Grace Therapeutics,, you can compare the effects of market volatilities on Telix Pharmaceuticals and Grace Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Grace Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Grace Therapeutics,.

Diversification Opportunities for Telix Pharmaceuticals and Grace Therapeutics,

0.27

Correlation Coefficient

Telix Pharmaceuticals  Grace Therapeutics,

Modest diversification

The 3 months correlation between Telix and Grace is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals Limited and Grace Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grace Therapeutics, and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals Limited are associated (or correlated) with Grace Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grace Therapeutics, has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Grace Therapeutics, go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Grace Therapeutics,

Considering the 90-day investment horizon Telix Pharmaceuticals Limited is expected to generate 38.09 times more return on investment than Grace Therapeutics,. However, Telix Pharmaceuticals is 38.09 times more volatile than Grace Therapeutics,. It trades about 0.17 of its potential returns per unit of risk. Grace Therapeutics, is currently generating about 0.02 per unit of risk. If you would invest  0.00  in Telix Pharmaceuticals Limited on October 4, 2024 and sell it today you would earn a total of  1,540  from holding Telix Pharmaceuticals Limited or generate 9.223372036854776E16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	6.87%
Values	Daily Returns

Telix Pharmaceuticals Limited  vs.  Grace Therapeutics,

Telix Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals Limited are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong essential indicators, Telix Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Grace Therapeutics,

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Grace Therapeutics, are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, Grace Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Telix Pharmaceuticals and Grace Therapeutics,

The main advantage of trading using opposite Telix Pharmaceuticals and Grace Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Grace Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grace Therapeutics, will offset losses from the drop in Grace Therapeutics,'s long position.

The idea behind Telix Pharmaceuticals Limited and Grace Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.